ModelEdge

Arca Biopharma Inc.
ABIO
Filing Type10-K
Filing Date3/5/2025
Updated3/6/25, 2:02 PM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2024
EX-4.1DESCRIPTION OF SECURITIES
EX-4.3FORM OF PRE-FUNDED WARRANT, DATED AUGUST 29, 2024
EX-10.17AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTICS, INC. AND PAUL QUINLAN, DATED OCTOBER 1, 2024
EX-10.18AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTICS, INC. AND JOANA GONCALVES, DATED OCTOBER 1, 2024
EX-10.19FORM OF INDEMNIFICATION AGREEMENT
EX-10.20NON-EMPLOYEE DIRECTORS COMPENSATION PROGRAM
EX-10.29IL-17 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THERAPEUTICS, INC., DATED FEBRUARY 4, 2025
EX-10.31IL-23 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THERAPEUTICS, INC., DATED DECEMBER 17, 2024
EX-10.32CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS IRELAND LIMITED AND ORUKA THERAPEUTICS, INC., DATED MARCH 4, 2024
EX-10.33AMENDMENT NO. 1 TO THE CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS IRELAND LIMITED AND ORUKA THERAPEUTICS, INC., DATED NOVEMBER 20, 2024
EX-19.1INSIDER TRADING POLICY
EX-21.1LIST OF SUBSIDIARIES OF THE REGISTRANT
EX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.1CERTIFICATION
EX-31.2CERTIFICATION
EX-32.1CERTIFICATION
EX-97.1INCENTIVE COMPENSATION CLAWBACK POLICY
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic